After Hours
$
33.96
Change
0.00 0.00%
Volume
Volume 11,266
Sep 22, 2023, 4:16 p.m.
Quotes are delayed by 20 min
Previous close
$ 35.00
$ 33.96
Change
-1.04 -2.97%
Day low
Day high
$33.63
$35.70

52 week low
52 week high
$16.73
$48.92

Market cap
$1.64B
Average volume
427,938
P/E ratio
N/A
Rev. per Employee
$328,714
EPS
-4.08
Dividend
N/A
Div yield
N/A
Ex dividend date
N/A
MarketWatch News on ACLX
-
Alibaba, Dice, Lemonade, Arcellx, Avis, and More Stock Market Movers
- Barron's Online
-
Arcellx started at buy with $60 stock price target at Truist
- Tomi Kilgore
-
Arcellx started at buy with $43 stock price target at Stifel Nicolaus
- Tomi Kilgore
-
Arcellx price target raised to $40 from $36 at Guggenheim
- Emily Bary
-
Arcellx price target lifted to $35 from $31 at Needham
- Emily Bary
-
Arcellx shares jump 6% in premarket after Gilead pact
- Steve Gelsi
-
AN2 Therapeutics Will Trade Friday. Now There Are 2 March IPOs.
- Barron's Online
-
Arcellx started at buy with $24 stock price target at BofA Securities
- Tomi Kilgore
-
Arcellx and Nuvectis Pharma Begin Trading. Here's how They Did.
- Barron's Online
-
Arcellx sets IPO terms, looks to raise up to $140.3 million
- Tomi Kilgore
Other News on ACLX
-
- Edgar Online - (EDG = 10Q, 10K)
-
- Edgar Online - (EDG = 10Q, 10K)
-
Cormorant Asset Management, LP Buys 2, Sells 3 in 4th Quarter
- GuruFocus.com
-
Top 5 4th Quarter Trades of NEA Management Company, LLC
- GuruFocus.com
-
- Edgar Online - (EDG = 10Q, 10K)
-
AJU IB Investment Co., Ltd. Buys 3, Sells 2 in 2nd Quarter
- GuruFocus.com
-
ASCO 2022: Surprising News in Cancer Research
- Motley Fool
Press Releases on ACLX
-
Arcellx Provides First Quarter Financial Results
- PR Newswire - PRF
-
Arcellx to Participate at the H.C. Wainwright Cell Therapy Virtual Conference
- PR Newswire - PRF
-
Arcellx Reports Third Quarter 2022 Financial Results and Business Progress
- PR Newswire - PRF
Rates »
National averages from Bankrate.com
National averages from Bankrate.com
National averages from Bankrate.com